CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pang, W.-W.
Right arrow Articles by Tung, C.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pang, W.-W.
Right arrow Articles by Tung, C.-C.
Canadian Journal of Anesthesia 50:48-51 (2003)
© Canadian Anesthesiologists' Society, 2003

Regional Anesthesia and Pain

Tramadol 2.5 mg·kg-1 appears to be the optimal intraoperative loading dose before patient-controlled analgesia

[Une dose de 2,5 mg·kg-1 de tramadol semble la dose d’attaque peropératoire optimale avant l’analgésie auto-contrôlée]

Wei-Wu Pang, MD*, Hurng-Sheng Wu, MD{dagger} and Chien-Chiung Tung, MD{ddagger}

* From the Department of Anesthesia,
{dagger} Show-Chwan Memorial Hospital Changhua The Department Of Surgery,
{ddagger} Show-Chwan Memorial Hospital Changhua National Defense Medical Center Tri-service General Hospital Taipei The Department Of Anesthesia Chen-Ching Hospital Wu-Fong Taichung Taiwan R.O.C.

Address correspondence to: Dr. Wei-Wu Pang, 7630 Pissarro Dr. Apt #108, Orlando, Florida 32819, USA. Phone: 407-351-8246; Fax: 407-351-8246; E-mail: sungfangrong{at}aol.com

Purpose: We previously established that a 5 mg•kg-1 intraoperative dose can reduce the nausea/vomiting associated with tramadol patient-controlled analgesia (PCA). This study was conducted to identify the most appropriate initial dose to improve the quality of tramadol PCA.

Methods: During general anesthesia, 60 patients undergoing knee arthroplasty were randomly allocated to receive 1.25 mg•kg-1 (Group I), 2.5 mg•kg-1 (Group II), 3.75 mg•kg-1 (Group III), or 5 mg•kg-1 (Group IV) tramadol. The emergence condition was recorded. The titration of additional tramadol 20 mg + metoclopramide 1 mg doses by PCA every five minutes was performed in the postanesthesia care unit (PACU) until the visual analogue scale (VAS) score was # 3. An investigator blinded to study group recorded the VAS and side effects every ten minutes.

Results: In the PACU, significantly more tramadol (8.4 ± 3.1 vs 4.3 ± 2.1, 2.5 ± 1.8, and 0.4 ± 0.3, P < 0.05), and a higher incidence (15/15 vs 5/15, 3/15, and 2/15, P < 0.05) of PCA use was observed in Group I compared to Groups II–IV. VAS was significantly higher in Group I than in Groups II–IV at zero and ten minutes (P < 0.05). Unexpected delayed emergence anesthesia (> 30 min) was observed in Group III (n = 1) and in Group IV (n = 2). Sedation was more important in Groups III and IV than in Groups I and II (P < 0.05).

Conclusion: When considering efficacy and side-effect profile, 2.5 mg•kg-1 of tramadol is the optimal intraoperative dose of this drug to provide effective postoperative analgesia with minimal sedation.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
H.-F Gramke, J. J. J. Petry, M. E. Durieux, J.-P Mustaki, M. Vercauteren, G. Verheecke, and M. A. E. Marcus
Sublingual piroxicam for postoperative analgesia: preoperative versus postoperative administration: a randomized, double-blind study.
Anesth. Analg., March 1, 2006; 102(3): 755 - 758.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Canadian Anesthesiologists' Society.